Suppr超能文献

三磷酸腺苷(ATP)与多药耐药蛋白MRP1的第一个核苷酸结合结构域结合,会增加ATP的结合与水解以及二磷酸腺苷(ADP)在第二个结构域的捕获。

ATP binding to the first nucleotide-binding domain of multidrug resistance protein MRP1 increases binding and hydrolysis of ATP and trapping of ADP at the second domain.

作者信息

Hou Yue-xian, Cui Liying, Riordan John R, Chang Xiu-bao

机构信息

Mayo Foundation, S. C. Johnson Medical Research Center, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259, USA.

出版信息

J Biol Chem. 2002 Feb 15;277(7):5110-9. doi: 10.1074/jbc.M107133200. Epub 2001 Dec 7.

Abstract

Multidrug resistance protein (MRP1) utilizes two non-equivalent nucleotide-binding domains (NBDs) to bind and hydrolyze ATP. ATP hydrolysis by either one or both NBDs is essential to drive transport of solute. Mutations of either NBD1 or NBD2 reduce solute transport, but do not abolish it completely. How events at these two domains are coordinated during the transport cycle have not been fully elucidated. Earlier reports (Gao, M., Cui, H. R., Loe, D. W., Grant, C. E., Almquist, K. C., Cole, S. P., and Deeley, R. G. (2000) J. Biol. Chem. 275, 13098-13108; Hou, Y., Cui, L., Riordan, J. R., and Chang, X. (2000) J. Biol. Chem. 275, 20280-20287) indicate that intact ATP is observed bound at NBD1, whereas trapping of the ATP hydrolysis product, ADP, occurs predominantly at NBD2 and that trapping of ADP at NBD2 enhances ATP binding at NBD1 severalfold. This suggested transmission of a positive allosteric interaction from NBD2 to NBD1. To assess whether ATP binding at NBD1 can enhance the trapping of ADP at NBD2, photoaffinity labeling experiments with [alpha-(32)P]8-N(3)ADP were performed and revealed that when presented with this compound labeling of MRP1 occurred at both NBDs. However, upon addition of ATP, this labeling was enhanced 4-fold mainly at NBD2. Furthermore, the nonhydrolyzable ATP analogue, 5'-adenylylimidodiphosphate (AMP-PNP), bound preferentially to NBD1, but upon addition of a low concentration of 8-N(3)ATP, the binding at NBD2 increased severalfold. This suggested that the positive allosteric stimulation from NBD1 actually involves an increase in ATP binding at NBD2 and hydrolysis there leading to the trapping of ADP. Mutations of Walker A or B motifs in either NBD greatly reduced their ability to be labeled by [alpha-(32)P]8-N(3)ADP as well as by either [alpha-(32)P]- or [gamma-(32)P]8-N(3)ATP (Hou et al. (2000), see above). These mutations also strongly diminished the enhancement by ATP of [alpha-(32)P]8-N(3)ADP labeling and the transport activity of the protein. Taken together, these results demonstrate directly that events at NBD1 positively influence those at NBD2. The interactions between the two asymmetric NBDs of MRP1 protein may enhance the catalytic efficiency of the MRP1 protein and hence of its ATP-dependent transport of conjugated anions out of cells.

摘要

多药耐药蛋白(MRP1)利用两个不等价的核苷酸结合结构域(NBDs)来结合并水解ATP。任一或两个NBDs水解ATP对于驱动溶质转运至关重要。NBD1或NBD2的突变会降低溶质转运,但不会完全消除。在转运循环中这两个结构域的事件是如何协调的尚未完全阐明。早期报告(高,M.,崔,H.R.,洛,D.W.,格兰特,C.E.,阿尔姆奎斯特,K.C.,科尔,S.P.,和迪利,R.G.(2000年)《生物化学杂志》275,13098 - 13108;侯,Y.,崔,L.,里奥丹,J.R.,和常,X.(2000年)《生物化学杂志》275,20280 - 20287)表明观察到完整的ATP结合在NBD1上,而ATP水解产物ADP主要被困在NBD2上,并且ADP在NBD2上的捕获使NBD1上的ATP结合增强了几倍。这表明存在从NBD2到NBD1的正构象相互作用传递。为了评估NBD1上的ATP结合是否能增强NBD2上ADP的捕获,用[α-(32)P]8-N(3)ADP进行了光亲和标记实验,结果显示当用这种化合物处理时,MRP1在两个NBDs上都有标记。然而,加入ATP后,这种标记主要在NBD2上增强了4倍。此外,不可水解的ATP类似物5'-腺苷酰亚胺二磷酸(AMP-PNP)优先结合到NBD1上,但加入低浓度的8-N(3)ATP后,NBD2上的结合增加了几倍。这表明来自NBD1的正构象刺激实际上涉及NBD2上ATP结合的增加及其水解导致ADP的捕获。NBD中沃克A或B基序的突变极大地降低了它们被[α-(32)P]8-N(3)ADP以及[α-(32)P]-或[γ-(32)P]8-N(3)ATP标记的能力(侯等人(2000年),见上文)。这些突变也强烈削弱了ATP对[α-(32)P]8-N(3)ADP标记的增强作用以及该蛋白的转运活性。综上所述,这些结果直接证明了NBD1上的事件对NBD2上的事件有正向影响。MRP1蛋白的两个不对称NBDs之间的相互作用可能会提高MRP1蛋白的催化效率,从而提高其将结合阴离子从细胞中ATP依赖性转运的效率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验